Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Animal Food Labeling; Declaration of Certifiable Color Additives, 57002 [2015-23566]

Download as PDF 57002 Federal Register / Vol. 80, No. 182 / Monday, September 21, 2015 / Notices Identify comments with the docket number found in brackets in the heading of this document. The guidances, notices, and received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday, and will be posted to the docket at https:// www.regulations.gov. OMB control number 0910–0721. The approval expires on August 31, 2018. A copy of the supporting statement for this information collection is available on the Internet at https://www.reginfo.gov/ public/do/PRAMain. Dated: September 11, 2015. Leslie Kux, Associate Commissioner for Policy. V. Electronic Access Persons with access to the Internet may obtain the document at either https://www.fda.gov/Drugs/ GuidanceCompliance RegulatoryInformation/Guidances/ default.htm or https:// www.regulations.gov. [FR Doc. 2015–23566 Filed 9–18–15; 8:45 am] Dated: September 15, 2015. Leslie Kux, Associate Commissioner for Policy. [Docket No. FDA–2015–N–3224] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Request for Nominations of Individuals and Consumer Organizations for the Patient Engagement Advisory Committee [FR Doc. 2015–23571 Filed 9–18–15; 8:45 am] BILLING CODE 4164–01–P AGENCY: Food and Drug Administration, HHS. DEPARTMENT OF HEALTH AND HUMAN SERVICES ACTION: Food and Drug Administration SUMMARY: [Docket No. FDA–2009–N–0025] Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Animal Food Labeling; Declaration of Certifiable Color Additives AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that a collection of information entitled ‘‘Animal Food Labeling; Declaration of Certifiable Color Additives’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE–14526, Silver Spring, MD 20993–0002, PRAStaff@ fda.hhs.gov. SUPPLEMENTARY INFORMATION: On July 16, 2015, the Agency submitted a proposed collection of information entitled ‘‘Animal Food Labeling; Declaration of Certifiable Color Additives’’ to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned rmajette on DSK7SPTVN1PROD with NOTICES SUMMARY: VerDate Sep<11>2014 15:14 Sep 18, 2015 Jkt 235001 Notice. The Food and Drug Administration (FDA) is requesting that any consumer organizations interested in participating in the selection of a voting consumer representative to serve on the Patient Engagement Advisory Committee (the Committee) notify FDA in writing. FDA is also requesting nominations for a voting consumer representative to serve on the Committee. Nominees recommended to serve as a voting consumer representative may either be selfnominated or may be nominated by a consumer organization. Nominations will be accepted for the current vacancy effective with this notice. FDA seeks to include the views of women and men, members of all racial and ethnic groups, and individuals with and without disabilities on its advisory committees and, therefore encourages nominations of appropriately qualified candidates from these groups. DATES: Any consumer organization interested in participating in the selection of an appropriate voting member to represent consumer interests on the Committee may send a letter or email stating that interest to FDA by October 21, 2015. Concurrently, nomination materials for prospective candidates should be sent to FDA by October 21, 2015. ADDRESSES: All statements of interest from consumer organizations interested in participating in the selection process should be sent electronically to Kimberly Hamilton (see FOR FURTHER INFORMATION CONTACT). All Consumer PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 Representative nominations may be submitted electronically by accessing the FDA Advisory Committee Membership Nomination Portal: https:// www.accessdata.fda.gov/scripts/ FACTRSPortal/FACTRS/index.cfm, by mail to Advisory Committee Oversight and Management Staff, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 5103, Silver Spring, MD 20993–0002, or FAX: 301–847– 8640. Information about becoming a member of an FDA advisory committee can also be obtained by visiting FDA’s Web site at https://www.fda.gov/ AdvisoryCommittees/default.htm. FOR FURTHER INFORMATION CONTACT: For questions relating to participation in the selection process: Kimberly Hamilton, Advisory Committee Oversight and Management Staff, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 5117, Silver Spring, MD 20993–0002, 301–796–6319, kimberly.hamilton@fda.hhs.gov. For questions relating to the Committee: Letise Williams, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 5441, Silver Spring, MD 20993–0002, 301– 796–8398, letise.williams@fda.hhs.gov. SUPPLEMENTARY INFORMATION: FDA is requesting nominations for a voting consumer representative on the Committee. Elsewhere in this issue of the Federal Register, FDA is publishing separate documents regarding: 1. Patient Engagement Advisory Committee; Notice of Establishment. 2. Request for Nominations for Voting Members for the Patient Engagement Advisory Committee. 3. Request for Nominations of Individuals and Industry Organizations for the Patient Engagement Advisory Committee. I. General Description of the Committee’s Duties The Committee provides advice on complex issues relating to medical devices, the regulation of devices, and their use by patients. Agency guidance and policies, clinical trial or registry design, patient preference study design, benefit-risk determinations, device labeling, unmet clinical needs, available alternatives, patient reported outcomes and device-related quality of life or health status issues are among the topics that may be considered by the Committee. Members are knowledgeable in areas such as clinical research, primary care patient experience, health care needs of patient groups in the E:\FR\FM\21SEN1.SGM 21SEN1

Agencies

[Federal Register Volume 80, Number 182 (Monday, September 21, 2015)]
[Notices]
[Page 57002]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-23566]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2009-N-0025]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; Animal Food Labeling; Declaration of 
Certifiable Color Additives

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Animal Food Labeling; Declaration 
of Certifiable Color Additives'' has been approved by the Office of 
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, 
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver 
Spring, MD 20993-0002, PRAStaff@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: On July 16, 2015, the Agency submitted a 
proposed collection of information entitled ``Animal Food Labeling; 
Declaration of Certifiable Color Additives'' to OMB for review and 
clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, 
and a person is not required to respond to, a collection of information 
unless it displays a currently valid OMB control number. OMB has now 
approved the information collection and has assigned OMB control number 
0910-0721. The approval expires on August 31, 2018. A copy of the 
supporting statement for this information collection is available on 
the Internet at https://www.reginfo.gov/public/do/PRAMain.

    Dated: September 11, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-23566 Filed 9-18-15; 8:45 am]
BILLING CODE 4164-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.